Long-term effectiveness of cognitive therapy in major depressive disorder

Depression and Anxiety

Volumn 20, Issue 1, 2004, Pages 1-7

  Hensley, Paula L ^a,b   Nadiga, Deepa ^a   Uhlenhuth, E H ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Adult; Antidepressive agents; Cognitive therapy; Depressive disorder; Follow up studies

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG DOSE REGIMEN; DRUG EFFICACY; EVALUATION; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAPSE; REMISSION; REVIEW; SHORT COURSE THERAPY;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FOLLOW-UP STUDIES; HUMANS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 4944264476     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.20022     Document Type: Review

References (22)

1. Barlow DH, Gorman JM, Shear MK, Woods SW. 2000. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial, JAMA 283:2529-2536.
2. Beck AT. 1967. Depression: Causes and treatment. Philadelphia: University of Pennsylvania Press.
3. Blackburn IM, Bishop S, Glen AIM, Whalley LJ, Christie JE. 1981. The efficacy of CT in depression: A treatment trial using CT and pharmacotherapy, each alone and in combination. Br J Psychiatry Suppl 139:181-189.
4. Blackburn IM, Eunson KM, Bishop S. 1986. A two-year naturalistic follow-up of depressed patients treated with CT, pharmacotherapy and a combination of both. J Affect Disord 10:67-75.
5. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. 1989. National Institute of Mental Health treatment of depression collaborative research program. General effectiveness of treatments [see comments]. Arch Gen Psychiatry 46:971-982.
6. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB. 1992. Differential relapse following CT and pharmacotherapy for depression. Arch Gen Psychiatry 49:802-808.
7. Gaffan EA, Tsaousis I, Kemp-Wheeler SM. 1995. Researcher allegiance and meta-analysis: The case of CT for depression. J Consult Clin Psychol 63:966-980.
8. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. 1998. A meta-analysis of the effects of CT in depressed patients. J Affect Disord 49:59-72.
9. Hollon SD, DeRubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, Tuason VB. 1992. CT and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry 49:774-781.
10. Klein DF. 1996. Preventing hung juries about therapy studies. J Consult Clin Psychol 64:81-87.
11. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. 1984. Interpersonal psychotherapy of depression. New York: Basic Books.
12. Kovacs M, Rush AJ, Beck AT, Hollon SD. 1981. Depressed outpatients treated with CT or pharmacotherapy: A one-year follow-up. Arch Gen Psychiatry 38:33-39.
13. Luborsky L, Diguer L, Seligman DA, Rosenthal R, Krause ED, Johnson S, Halperin G, Bishop M, Berman JS, Schweizer E. 1999. The researcher's own therapy allegiances: A "wild card" in comparison of treatment efficacy. Clin Psychol Sci Pract 6:95-106.
14. Mulrow CD, Williams JW, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K. 2000. Efficacy of newer medications for treating depression in primary care patients. Am J Med 108:54-64.
15. Murphy GE, Simons AD, Wetzel RD, Lustman PJ. 1984. CT and pharmacotherapy: Singly and together in the treatment of depression. Arch Gen Psychiatry 41:33-41.
16. Nadiga D, Hensley PL, Uhlenhuth EH. 2003. Review of the long-term effectiveness of cognitive behavior therapy compared to medication in panic disorder. Depress Anxiety 17:58-64.
17. Rickels K, Noyes Jr. R, Robinson DS, Schweizer E, Uhlenhuth EH. 1994. Evaluating drug treatments of generalized anxiety disorder and adjustment disorders with anxious mood. In: Prien RF, Robinson DS, editors. Clinical evaluation of psychotropic drugs: Principles and guidelines. New York: Raven Press, Ltd. p 384.
18. Rosenbaum JF, Hylan TR. 1999. Costs of depressive disorders: A review. In: Maj M, Sartorius N, editors. Depressive disorders. Sussex: John Wiley & Sons Ltd. p 401-480.
19. Rush AJ, Beck AT, Kovacs M, Hollon S. 1977. Comparative efficacy of CT and pharmacotherapy in the treatment of depressed outpatients. CT and Research 1:17-37.
20. Sharp DM, Power KG, Simpson RJ, Swanson V, Moodie E, Anstee JA, Ashford JJ. 1996. Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord 10:219-242.
21. Shea MT, Elkin I, Imber SD, Sotsky SM, Watkins JT, Collins JF, Pilkonis PA, Beckham E, Glass DR, Dolan RT, Parloff MB. 1992. Course of depressive symptoms over follow-up: Findings from the National Institute of Mental Health treatment of depression collaborative research program. Arch Gen Psychiatry 49:782-787.
22. Simons AD, Murphy GE, Levine JL, Wetzel RD. 1986. CT and pharmacotherapy for depression: sustained improvement over one year. Arch Gen Psychiatry 43:43-48.